Gene · 23607
Papers1,907
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,907
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tau dysfunction in alzheimer's disease: molecular and cellular mechanisms, genetic modulation, and therapeutic perspectives. | Mol Biol Rep | 2026 | 42593621 | PubTator, text mining | PubMed |
| Inhibitory TIGIT signaling is dependent on T cell receptor activation. | Cell Rep | 2026 | 42560817 | PubTator, text mining | PubMed |
| Alphavirus nsP3 as a multifunctional orchestrator of virus-host interplay. | J Virol | 2026 | 42294907 | PubTator, text mining | PubMed |
| The Phosphoproteomic Landscape of CD2AP: A Comprehensive Review of Kinase Networks and Disease Implications. | OMICS | 2026 | 42159329 | PubTator, text mining | PubMed |
| Shared Genetic Architecture Between Kidney Function and Alzheimer Disease Across Ancestries. | medRxiv | 2026 | 42006785 | PubTator, text mining | PubMed |
| Recurrence of focal segmental glomerulosclerosis: An updated review of pathophysiology, biomarkers, and therapeutic strategies. | Cell Transplant | 2026 | 41906863 | PubTator, text mining | PubMed |
| Programmed cell death: a promising management for Alzheimer's disease. | Apoptosis | 2026 | 41904723 | PubTator, text mining | PubMed |
| Extracellular Vesicles Associated Metabolites as Intercellular Signalling Mediators in Disease and Therapy. | Metabolites | 2026 | 41893356 | PubTator, text mining | PubMed |
| Nephroprotective Effects of Vanillic Acid on Bortezomib-Induced Renal Injury: Role of Oxidative Stress, Mitochondrial Dysfunction, Apoptosis and miR-204/Nephrin/Podocin/CD2AP Axis. | Basic Clin Pharmacol Toxicol | 2026 | 41862410 | PubTator, text mining | PubMed |
| Circular RNAs in sepsis-induced acute lung injury: emerging mechanisms and therapeutic potential. | Front Immunol | 2026 | 41789098 | PubTator, text mining | PubMed |
| Molecular mechanisms in podocytopathies: finding suitable targets for a new era of glomerular gene therapy. | Clin Kidney J | 2026 | 41788620 | PubTator, text mining | PubMed |
| Lactylation: a metabolic-epigenetic bridge in diabetic kidney disease and a therapeutic target for TCM. | Chin Med | 2026 | 41787542 | PubTator, text mining | PubMed |
| Epigenetic mechanisms and steroid-resistant nephrotic syndrome: The future potential for SRNS diagnosis. | iScience | 2026 | 41782821 | PubTator, text mining | PubMed |
| Tankyrases and Their Binding Proteins: Origins of Their Roles in Diverse Cellular Pathways. | Cells | 2026 | 41744791 | PubTator, text mining | PubMed |
| Endocytic scaffolds at the crossroads of Alzheimer's disease and neuronal aging. | Biol Chem | 2026 | 41696979 | PubTator, text mining | PubMed |
| Identification of disulfidptosis-related genes in immunity and immunotherapy in diabetic foot ulcer. | Ann Med Surg (Lond) | 2026 | 41675755 | PubTator, text mining | PubMed |
| Genetic risk factors of late-onset Alzheimer's disease: Insights into pathophysiology and emerging therapeutic directions. | Neural Regen Res | 2026 | 41622452 | PubTator, text mining | PubMed |
| Consanguinity-linked genetic variants in Algerian patients with steroid-resistant nephrotic syndrome: a familial study. | Pediatr Nephrol | 2026 | 41612037 | PubTator, text mining | PubMed |
| Machine learning identifies disulfidptosis-related gene signature for pancreatic cancer prognosis and immune infiltration. | Discov Oncol | 2026 | 41591656 | PubTator, text mining | PubMed |
| Proteomic Profiling of Non-Muscle Invasive Bladder Cancer Reveals Potential Biomarkers for Recurrence and Progression Risk. | J Proteome Res | 2026 | 41587934 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23607/papers